Soapwort

Generic name: Saponaria Officinalis L.
Brand names: Bouncing Bet, Bruisewort, Dog Cloves, Fuller's Herb, Lady's-washbowl, Latherwort, Old-maid's-pink

Usage of Soapwort

Antifungal activity

In vitro and animal data

Saponin-rich fractions extracted from Medicago sativa and S. officinalis were tested in vitro for activity against Candida albicans reference strain and 5 clinical strains for direct fungicidal and fungistatic activity. The extracts were tested alone as well as in combination with various antimycotics (eg, amphotericin B, miconazole, clotrimazole, ketoconazole, nystatin, natamycin, flucytosine). Although S. officinalis extract did not exhibit direct antifungal activity, it did exert strong germ tube formation inhibition and a potent synergy with caspofungin that almost completely inhibited biofilm formation. S. officinalis also demonstrated very high cytotoxicity when used at both high and low concentrations, making it a more likely candidate as an antifungal disinfectant than therapeutic agent; the high cytotoxicity of S. officinalis saponin-rich extract corresponded to its hemolytic activity.Sadowska 2014

Clinical data

Research reveals no clinical data regarding use of soapwort as an antifungal.

Anti-HIV activity

In vitro and animal data

Similar to many other type 1 ribosome-inhibiting proteins, saporin possesses potent anti-HIV integrase activity in vitro.Au 2000, Yadav 2015 The anti-HIV activity of saporin, as well as of 3 saporin mutants, was assayed to further define its anti-HIV mechanism of action. According to the results, saporin appears to enter cells via nonreceptor-mediated endocytosis and exhibits dose-dependent anti-HIV activity. The results also indicate that the anti-HIV activity of saporin is independent of its N-glycosidase activity; however, it appears to be associated with its apoptosis-inducing activity and in turn its cytotoxic activity.Yadav 2015

Clinical data

Research reveals no clinical data regarding use of soapwort as an anti-HIV agent.

Antitumor activity

Protein synthesis is inactivated by saporin through the irreversible removal of an essential adenine. Because the cytotoxicity of saporin alone is low, it is conjugated with specific targeting ligands (ie, monoclonal antibodies, growth factors) to direct the toxic potential of saporin to cancer cells that are overexpressing cancer-associated antigens. Combining saporin and the targeting ligand with another saponin augments the delivery of the antitumor toxin to the cancer cell cytosol.Weng 2012

Experimental and animal data

The antitumor effect of the immunotoxin saporin-S6-rituximab conjugate was assessed in CD20+ lymphoma cell lines; both a dimeric and monomeric conjugate were tested. Saporin-S6 showed increased cytotoxicity after conjugation with rituximab; the dimeric (high-molecular-weight immunotoxin) was more active than the monomeric.Bortolotti 2016 In another series of in vitro and in vivo studies based on previous results demonstrating that saporin fused with epidermal growth factor (Sap3-EGF) reduces tumor volume more than 94%, a highly purified single saponin extracted from the roots of S. officinalis (SO-1861) was combined with Sap3-EGF as a targeted toxin to determine cytotoxic efficacy. In vitro tests confirmed a 6,900-fold increase in cytotoxicity in a synergistic fashion. According to the acute toxicity studies in mice, the purified saponin was nontoxic up to a dose of 100 mcg per treatment. An acute dose of 200 mcg of the purified saponin (SO-1861) resulted in severe liver damage and was fatal in all mice by day 2, whereas no animals in the 100 mcg group died during the 28-day study period. The combination of SO-1861 30 mcg plus Sap3-EGF 0.1 mcg reduced the average tumor volume by more than 90% compared with placebo-treated mice. Additionally, 8 of 10 treated mice exhibited complete remission compared with 1 in 8 controls.Thakur 2013 Similar results have been reported using the purified triterpenoid saponin SO-1641 in combination with saporin-EGF in tumor-bearing mice.Weng 2012 Similar results were also observed when SO-1861 was combined with saporin-rituximab, which produced an approximate 700-fold increase in cytotoxicity in human B-cell Burkitt lymphoma cells.Gilabert-Oriol 2016 The use of the saponin SO-1861 with lipid-based and peptide nanocarriers for the efficient delivery of DNA and/or siRNA to cells has also been demonstrated in 3 different cell lines.Weng 2015

The crude extracts from 4 species of the Caryophyllaceae family, including S. officinalis, were tested for cytotoxic effects in rat and human macrophage cell lines. S. officinalis extract exhibited the most cytotoxic activity among the extracts tested in the rat alveolar macrophage cells and reduced cell viability by 60% (P<0.0001), but was less cytotoxic than Dianthus sylvestris extract in human monocytes. S. officinalis was 1 of 3 extracts to demonstrate time-dependent caspase-3 activation of apoptosis.Gevrenova 2014

Clinical data

In 1992, patients with advanced Hodgkin disease (n=16) were enrolled in the first phase 1/2 clinical trial testing a saporin-S6–containing immunotoxin. Saporin-S6 was conjugated with anti-CD30 Ber-H2 and administered intravenously at 0.2 mg/kg as saporin-S6 (0.8 mg/kg as immunotoxin) in 1 or 2 weekly doses. Overall, tumor mass was reduced in 60% of cases, with partial remission in approximately 42% of patients; responses lasted between 2 and 4 months. About 70% of patients experienced adverse reactions (eg, fever, myalgias, vascular leak syndrome, hepatotoxicity, thrombocytopenia). Weekly infusions containing escalating saporin-S6 doses ranging from 1 to 4 mg/dose (total of 5 to 20 mg) were used in 2 other early phase 1/2 trials in 1995 and 1996, with results varying from complete clearance of tumor in one patient with end-stage non-Hodgkin lymphoma to no response in a patient with end-stage chronic lymphocytic leukemia. When responses occurred, they were rapid but persisted for less than 28 days.Polito 2013

Bone cancer pain

Animal data

Bone cancer in companion dogs is an animal model of naturally occurring bone cancer that closely mirrors the disease and its progression in humans. In a single-blind, randomized controlled trial, the analgesic and functional efficacy of a single intrathecal dose of a substance P saporin (SP-SAP) conjugate immunotoxin that targets SP receptor–bearing neurons was evaluated in 70 companion dogs with appendicular bone cancer. SP-SAP was dosed at 20, 40, or 60 mcg for dogs weighing 10 to 15 kg, 16 to 30 kg, or more than 30 kg, respectively. Outcomes were measured at 2 weeks and monthly thereafter. Dogs in the control group that received standard of care therapy alone required additional intervention (ie, analgesics, euthanasia) significantly sooner than those in the SP-SAP treatment group (P=0.002). The number of dogs that required additional intervention was also significantly higher in the control versus treatment group (74% vs 24%, respectively; P=0.001). Pain scores and lameness were not significantly different between groups; pain scores were not significantly different from baseline.Brown 2013

Soapwort side effects

Few adverse effects have been reported with oral ingestion, except in cases of underlying disease of the mucosa (ie, ulcers). Severe vomiting and diarrhea may occur if soapwort is ingested.Dobelis 1986 In early phase 1/2 clinical trials, saporin-S6–containing immunotoxins produced mild transient adverse reactions, including fever, myalgia, transient increases in transaminases, weakness, thrombocytopenia, and vascular leak syndrome. Fever and myalgia, effects commonly reported with immunotoxins, were treated with steroid therapy.Polito 2013

Before taking Soapwort

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking.

How to use Soapwort

Clinical evidence is lacking to support specific dosing recommendations.

Bronchitis and cough

Doses of 1 to 2 g daily of soapwort extract or 1.5 g daily of the root have been traditionally used.Blumenthal 1998

Cancer

In early phase 1/2 clinical trials (1992 to 1996) using saporin-S6 immunotoxin conjugates, saporin-S6 was administered at a dose of 0.2 mg/kg in 1 or 2 weekly doses intravenously in patients with advanced Hodgkin disease or weekly infusions of 1 to 4 mg/dose (for a total of 5 to 20 mg) in patients with B-cell lymphoma.Polito 2013

Warnings

None well documented. Women with vaginal infections should not use soaps or cleansing products made with soapwort; an in vitro study found increased growth of Trichomonas vaginalis in women treated with varying strengths of S. officinalis extracts.Hezarjaribi 2016

What other drugs will affect Soapwort

None well documented.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords